Transplantation of human iPS cell-derived glial-rich neural progenitor cells into ALS model mice extends their lifespans

Human somatic cells pass through a primitive streak-like stage during reprogramming – Partial elucidation of the reprogramming mechanism –

Study of the candidate factors responsible for the DNA demethylation required in iPS cell generation

Elucidation of carcinogenic mechanism not involving gene mutation Application of iPS cell technology

Method developed for using human iPS cells to create stable and large-scale supply of platelets

High-throughput screening (HTS) leads to discovery of compounds that induce efficient differentiation of human iPS cells into nephrogenic cells

Researchers develop method for generation and maintenance culture of human iPS cells suitable for use in cell transplantation

Successful replication of FOP pathology using patient-derived iPS cells

Method of large-scale erythrocyte production established using erythrocyte progenitor cells with high replication ability

Method for identifying low-quality pluripotent stem cells developed using large-scale analysis

Global Splicing Pattern Reversion during Somatic Cell Reprogramming

Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate

Modeling of congenital amegakaryocytic thrombocytopenia using iPS cell technology

CiRA International Symposium 2014 to be held on January 17

Efficient and highly reproducible myocyte production from human iPS cells Toward development of a drug discovery platform for use with muscular diseases

Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells

CiRA International Symposium 2013 Raising the Next Generation of Stem Cell Research

Anacardic acid found to rescue certain ALS abnormalities in experimental drug screening assay using motor neurons from ALS patient-specific iPSCs

PNAS: Donor-dependent variation in hepatic differentiation from human iPS cells

Pathological analysis of CINCA syndrome using iPS cells

The CiRA International Symposium 2012 held with 270 participants

CiRA International Symposium 2012 to be held on February 23

CiRA International Symposium 2011 Cancelled

[Cencelled]CiRA Symposium for general public 2011 “Science is full of surprise! Challenge of scientists to cell reprogramming”

[Cancelled]CiRA International Symposium 2011 “iPS Cell Research: From Reprogramming to Clinical Application”

[Abstract submission is closed]Poster presentations at the CiRA International Symposium 2011

Website for the iPS Cell Applications in Regenerative Medicine project launched